Sanford Burnham Prebys announces start of Phase 2 clinical trial of DS-1211 in individuals with PseudoXanthoma Elasticum - Sanford Burnham Prebys
In The News

Sanford Burnham Prebys announces start of Phase 2 clinical trial of DS-1211 in individuals with PseudoXanthoma Elasticum

AuthorCommunications
Date

December 19, 2022

San Diego Biotech Networks News